Health Canada
Symbol of the Government of Canada

Common menu bar links

Drugs and Health Products

Approved conditions of use for Mifepristone and Misoprostol (sold in Canada as Mifegymiso)

Select country comparison (information current as of October 3, 2016)
  Canada USA UK France Netherlands Sweden Australia

Table 1 footnotes

Table 1 footnote 1

In Australia, retail pharmacies in certain states can stock and dispense the product once they have registered and been certified to do so. However, in the Northern Territory there is no current access to medical abortion and in South Australia only registered and certified hospital pharmacists can dispense the product.

Return to table 1 footnote * referrer

Table 1 footnote 2

Mifegymiso is comprised of 2 drugs, mifepristone and misoprostol. Mifepristone is taken first, under the supervision of a physician (or a health care provider who meets certain qualifications [United States]), in an appropriate setting as determined between the patient and physician. Misoprostol is taken 24-48 hours later. In Canada, patients are not required to take either drug in front of their doctor. The product monograph is worded to allow physicians to determine what is best for the individual patient. "Under the supervision of" is intended to give the prescriber the option to observe directly, delegate to another staff or to direct the patient as appropriate.

Return to table 1 footnote ** referrer

Retail pharmacist to patient dispensing? No No No No No No Yes, under certain conditionsTable 1 footnote *
Location of misoprostol administrationTable 1 footnote ** Medical office, clinic or at home At location deemed appropriate for patient Medical office or clinic; not at home Medical office or clinic; not at home Medical office or clinic; not at home Medical office or clinic; not at home Medical office, clinic or at home